168 related articles for article (PubMed ID: 32885780)
1. The Effects of Differing Invitation Models on the Uptake of Immunological Fecal Occult Blood Testing.
Gruner LF; Hoffmeister M; Ludwig L; Meny S; Brenner H
Dtsch Arztebl Int; 2020 Jun; 117(25):423-430. PubMed ID: 32885780
[TBL] [Abstract][Full Text] [Related]
2. Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial.
Gruner LF; Hoffmeister M; Ludwig L; Brenner H
JMIR Res Protoc; 2020 Apr; 9(4):e16413. PubMed ID: 32242518
[TBL] [Abstract][Full Text] [Related]
3. Invitation letters increase participation in colorectal cancer screening - results from an observational study.
Zhan T; Hielscher T; Bilge A; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2017 Dec; 55(12):1307-1312. PubMed ID: 29212101
[No Abstract] [Full Text] [Related]
4. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
[TBL] [Abstract][Full Text] [Related]
5. The effect of gender-specific invitation letters on utilization of colorectal cancer screening.
Zhan T; Hielscher T; Eckardt M; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2019 Sep; 57(9):1051-1058. PubMed ID: 31525797
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
Trials; 2013 Jul; 14():239. PubMed ID: 23902589
[TBL] [Abstract][Full Text] [Related]
7. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
[TBL] [Abstract][Full Text] [Related]
8. Reinvitation to screening colonoscopy: a randomized-controlled trial of reminding letter and invitation to educational meeting on attendance in nonresponders to initial invitation to screening colonoscopy (REINVITE).
Pisera M; Kaminski MF; Kraszewska E; Rupinski M; Regula J
Eur J Gastroenterol Hepatol; 2016 May; 28(5):538-42. PubMed ID: 26967693
[TBL] [Abstract][Full Text] [Related]
9. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
10. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.
Coronado GD; Rivelli JS; Fuoco MJ; Vollmer WM; Petrik AF; Keast E; Barker S; Topalanchik E; Jimenez R
J Gen Intern Med; 2018 Jan; 33(1):72-78. PubMed ID: 29019046
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials.
Gruner LF; Amitay EL; Heisser T; Guo F; Niedermaier T; Gies A; Hoffmeister M; Brenner H
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33806234
[TBL] [Abstract][Full Text] [Related]
12. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
13. Two randomized controlled trials for colorectal cancer screening invitations developed using a behavioral science approach.
Tinmouth J; Llovet D; Sutradhar R; Tsiplova K; Roushani J; Lee A; Hader J; Rabeneck L; Paszat L
Prev Med; 2022 Feb; 155():106918. PubMed ID: 34953810
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
[TBL] [Abstract][Full Text] [Related]
15. Screening for Bowel Cancer: Increasing Participation via Personal Invitation.
Hoffmeister M; Holleczek B; Zwink N; Stock C; Stegmaier C; Brenner H
Dtsch Arztebl Int; 2017 Feb; 114(6):87-93. PubMed ID: 28266301
[TBL] [Abstract][Full Text] [Related]
16. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate.
Blom J; Löwbeer C; Elfström KM; Sventelius M; Öhman D; Saraste D; Törnberg S
J Med Screen; 2019 Jun; 26(2):92-97. PubMed ID: 30336730
[TBL] [Abstract][Full Text] [Related]
17. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.
Goldshore MA; Mehta SJ; Fletcher W; Tzanis G; Doubeni CA; Paulson EC
Am J Prev Med; 2020 Jul; 59(1):41-48. PubMed ID: 32564804
[TBL] [Abstract][Full Text] [Related]
18. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
19. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
20. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
